TERUMO CARDIOVASCULAR SYSTEMS CORP.

Company Snapshot

Founded: 1999
Entity Type: Private
Region: North America
Headquarter: Michigan, U.S.
Key Geographics: North America, Central and South America, Europe, Middle East and Africa, Japan, East Asia, Asia-Pacific
Corporate Address: 6200 Jackson Road, Ann Arbor, Michigan 48103-9300 U.S. Tel. +1-734-663-4145 www.terumocv.com

Company Overview

Terumo Cardiovascular Group is a subsidiary company of Terumo Group. It was incorporated in 1999 and is headquartered in Michigan. The company also has a significant presence in the U.K. and Japan. The company develops, manufactures and distributes medical devices for vascular and cardiac surgery and offers a variety of products including autotransfusion products, heart beating and surgical stabilization products, endoscopic products, monitoring systems, perfusion products, and platelet therapy. Perfusion products include oxygenation systems, reservoirs, myocardial protection products, heart-lung machines, filters, and various others. These products are used during cardiac and thoracic surgery to temporarily replace the functions of the heart and lungs. The company also offers a single-use disposable centrifugal pump which handles air efficiently, generates low heat and hemolysis rate at the low prime volume of 48 ml.

TERUMO CARDIOVASCULAR SYSTEMS CORP. In Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

BCC Research Market Report for Single-use Biopharmaceutical’s technologies. Get market applications, such as monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives and anticancer...

Surgical Devices Market: A BCC Research Overview

The global surgical devices market should grow from $85.5 billion in 2019 to reach $138.5 billion by 2024 at a compound annual growth rate (CAGR) of 10.1% for the period of 2019-2024.

Single-use Technologies for Biopharmaceuticals: Global Markets

The global single-use technology in the biopharmaceutical market should reach $5.9 billion by 2024 from $3.5 billion in 2019 at a compound annual growth rate of 11.3% for the period of 2019 to 2024.